Market Insights Consumer OTC Pharmaceuticals

Analgesics - Worldwide

Worldwide

Revenue in the Analgesics market amounts to €30.64bn in 2024. The market is expected to grow annually by 6.73% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€6,716m in 2024).
In relation to total population figures, per person revenues of €3.96 are generated in 2024.

Key regions: United Kingdom, Indonesia, United States, Europe, Canada

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

Although the COVID-19 pandemic resulted in a reduction of selective procedures and surgeries, which leads to a decreasing sale of after-surgical pain killers, COVID-19-related symptoms such as muscle or body aches are driving the demand during the pandemic. In 2022, the global Analgesics market reached US$30.93 billion and recovered from a slight decline in 2020 brought about by the COVID-19 pandemic.

Another significant trend is the prevalence of chronic diseases, which leads to a growing demand for analgesics used by people suffering from chronic and severe pain. The growth of the Analgesics market is restricted by legislation, as the restriction on opioid analgesics differs from country to country.

In the forecast period, the market exhibits steady growth at a CAGR of around 6%, mainly based on the globally growing share of the elderly population and the correspondingly increasing demand. The global Analgesics market is expected to reach US$42.65 billion in 2027.

Methodology

The Analgesics market is built on resources from the Statista platform as well as on in-house market research, national statistical offices, international institutions, trade associations, companies, the trade press, and the experience of our analysts. We evaluate the status quo of the market, monitor trends, and create an independent forecast regarding market developments of the global Analgesics industry.